Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron

(marketscreener.com) Board of Directors appoints Isaac Israel, Board member and former CEO, as acting CEOCompany’s business plan and clinical development programs continue as planned REHOVOT, Israel, March 24, 2023 -- Purple Biotech Ltd. , a clinical-stage company developing first-in-class, effective and durable therapies that harness the power of...https://www.marketscreener.com/quote/stock/PURPLE-BIOTECH-LTD-120961141/news/Purple-Biotech-Reports-Temporary-Medical-Leave-of-CEO-Gil-Efron-43329772/?utm_medium=RSS&utm_content=20230324